Prognostic Factors Analysis for Colon Cancer with Lymph Node Negative

  1. Home
  2. Articles

Prognostic Factors Analysis for Colon Cancer with Lymph Node Negative

Ionuţ Vîlcea, Benoit Romain, Serge Rohr, Traean Burcoş
Original article, no. 4, 2018
Article DOI: 10.21614/chirurgia.113.4.503
Purpose: The analysis of high risk relapse prognosis factors and their importance regarding recurrence risk for stage I and II colon cancer, according to TNM classification 8th edition, 2017. Material and Method: We performed a retrospective analysis regarding the impact of prognosis factors for patients with high recurrence risk in stages I and II. We studied 99 patients with T2, T3 and T4 tumors who suffered a curative resection and whom may or may not present indication for adjuvant chemotherapy according to histoprognostic factors and molecular biomarkers. Results: We performed a univariate Cox regression which highlighted that male sex is a risk factor for disease relapse (HR=5.53, p 0.05, IC95% = 1.29 to 23.73). Although with a low statistical significance effect, T4 tumors seems to be associated with a poor prognosis regarding disease relapse (HR = 2.56, p = 0.06, IC95% = 0.94 to 6.99) compared to T2 and T3 tumors. Patients with d’MMR (MSI-H) seem to have a more favorable evolution compared to patients with p’MMR (MSS/MSI-L) â€" HR (d’MMR vs p’MMR) = 0.19, IC95% = 0.02 to 1.61, p = 0.13. Conclusions: We believe that it would be useful for MSS / MSI to be systematically analyzed, our data suggesting a better response of d`MMR patients to adjuvant chemotherapy. The multivariate Cox regression did not identify independent risk factors of relapse.

Keywords: colorectal cancer, prognosis factor, lymph node, chemotherapy